Health Optimization Index
Astaxanthin
- Nick’s assessment
- Favorable
- Research evidence
- C, mixed evidence
- Attention
- 7.6 / 100▼ Falling this week
BioHarmony score
Astaxanthin is a lipid-soluble xanthophyll carotenoid from Haematococcus pluvialis microalgae that spans cell membranes and concentrates in oxidative-stress-prone tissues. The best supported claims are antioxidant and inflammation-marker shifts, modest lipid effects, skin and eye support, and small exercise or fatigue signals. Newer reviews are directionally positive, including Liu 2024 for fatigue, cognition, and exercise efficiency, Laurindo 2025 for triglycerides and HDL-C, and Ma 2022 for oxidative stress and inflammation.
Read the full report Benefits, risks and practical guidance.
Read Nick’s assessment Why it earned this rating
Astaxanthin is a 7.5–8.0/10 fit for people weighing antioxidant, inflammation control, and skin resilience, especially when the goal is a tracked experiment with clear endpoints. The strongest evidence anchor is Dehpahni 2026: 10 studies including 3 clinical RCTs; after high-bias trial removal, no significant human semen-parameter improvements versus placebo. Malcangi 2026 adds a second signal, but Astaxanthin still has gaps around large trials, long-term outcomes, responder profiles, or real-world adherence. That makes Astaxanthin useful for a defined reader, while weaker for broad anti-aging or catch-all wellness claims. In practice, Astaxanthin belongs after basics, diagnosis when relevant, and a stop rule based on symptoms, labs, sleep, or performance.
✅ Best for: Adults 40+ wanting a broad antioxidant with real human RCT signal and low daily friction. Heavy screen users with eye fatigue who are already handling lighting, blinking, dry-eye basics, and screen ergonomics. Endurance athletes or high-volume exercisers looking for mild oxidative-stress and recovery support, especially after a 2-4 week loading window. People with visible photoaging who already use SPF, clothing, and shade. Dyslipidemic or prediabetic adults who understand Laurindo 2025 supports modest adjunctive lipid-marker movement, not AHA-grade lipid therapy. Women pursuing ART where clinician-supervised antioxidant support is appropriate, based on Maleki-Hajiagha 2024 and Rodrigues 2025 lab-endpoint signals. Anyone willing to source verified natural Haematococcus pluvialis extract and take it with fat.
❌ Avoid if: You take warfarin, DOACs, dual antiplatelet therapy, or have a bleeding disorder unless your clinician approves and monitors it. You are pregnant, lactating, under 14, or planning surgery in the next 2 weeks. You want an oral sunscreen, tanning pill, cardiovascular prevention pill, cancer-prevention supplement, or disease treatment; the FDA tanning-pill page, AAD sun guidance, AHA supplement guidance, and USPSTF supplement recommendation do not support those frames. Also avoid if you cannot take it with dietary fat, cannot verify product quality, or expect a dramatic acute effect from a subtle membrane antioxidant.
Share your experience
Your answers are optional and help other readers — they never change my score. How community input works.
One step left: confirm it’s you
New voice here? We send a one-tap verification link so every entry comes from a real person. Signed-in members skip this.
Make a 12-month prediction Will it rise or fall in the Index?
Choose a direction and your confidence. Correct predictions earn leaderboard points.
Your prediction is final once submitted. We’ll check it in 12 months. See the leaderboard →